Lucira Health, Inc. Common Stock
LHDX
LHDX was delisted on the 3rd of March, 2023.
38 hedge funds and large institutions have $42.2M invested in Lucira Health, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 7 closing their positions.
11% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 9
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 40 → 38 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
50% less capital invested
Capital invested by funds: $83.7M → $42.2M (-$41.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$793K |
| 2 |
CWA
Choice Wealth Advisors
Waterville,
Maine
|
+$237K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$213K |
| 4 |
Renaissance Technologies
New York
|
+$102K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$41.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.24M |
| 2 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$1.11M |
| 3 |
ECG
EPIQ Capital Group
San Francisco,
California
|
-$714K |
| 4 |
AI
Atom Investors
Austin,
Texas
|
-$307K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$210K |
LHDX Hedge Fund Activity: Q2 2022 in Review
38 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Lucira Health, Inc. Common Stock (LHDX) for Q2 2022, worth a combined $42.2M — down 50% from $83.7M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of LHDX and 5 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 10 added.
The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $793K. The largest seller was Millennium Management, cutting an estimated $1.24M.
- 38 institutional investors held Lucira Health, Inc. Common Stock (LHDX) as of Q2 2022, down from 40 in Q1 2022.
- Funds reported $42.2M of Lucira Health, Inc. Common Stock stock for Q2 2022, down 50% quarter-over-quarter.
- 5 funds opened new Lucira Health, Inc. Common Stock positions in Q2 2022 and 7 closed out, a net change of -2 holders.
- The largest Lucira Health, Inc. Common Stock buyer in Q2 2022 was Balyasny Asset Management, an estimated $793K added.
- The largest Lucira Health, Inc. Common Stock seller in Q2 2022 was Millennium Management, an estimated $1.24M sold.
Based on aggregated 13F filings for Q2 2022.